Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 452
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01886053 | A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia | ||
| NCT05107037 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of TQ-B3234 in Patients With Type I Neurofibromatosis | ||
| NCT06561607 | A Clinical Trial to Evaluate the Efficacy and Safety of TQB2102 for Injection Versus Investigator-Selected Chemotherapy in HER2 Low-Expressing Recurrent/Metastatic Breast Cancer | ||
| NCT05859373 | To Evaluate the Efficacy and Safety of TQB3728 Tablets in Sequential Maintenance of TQB2450 Injection Therapy in Patients After Sequential or Concurrent Chemoradiation for Locally Advanced Non-small Cell Lung Cancer. | ||
| NCT05020639 | A Study of TQB3820 in Patients With Hematological Malignancies | ||
| NCT01795716 | Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia Body | ||
| NCT07482592 | Clinical Trial of TQB3205 Capsule in Subjects With Advanced Malignant Tumors | ||
| NCT06552520 | To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis | ||
| NCT04007835 | Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCLC Patients With Acquired Resistance to EGFR-TKI | ||
| NCT06662760 | Clinical Trial of TQB3002 in Patients With Advanced Cancers | ||
| NCT05489276 | Clinical Trial of TQB2825 in Subjects With CD20 Positive Hematological Tumors | ||
| NCT06429397 | Anlotinib Combined With Benmelstobart for Advanced Pheochromocytoma | ||
| NCT06767813 | Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms | ||
| NCT07147946 | Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease | ||
| NCT07545213 | Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis | ||
| NCT07564505 | Post - Marketing Case Registration Study on the Safety and Efficacy of Adalimumab Solution for Injection in Chinese Pediatric Patients With Moderate - to - Severe Active Crohn's Disease | ||
| NCT07653685 | A Clinical Study of TQB2930 Injection and Chemotherapy With or Without Bevacizumab in the Treatment of Advanced Colorectal Cancer | ||
| NCT01878448 | A Phase II Study of Anlotinib in STS Patients | ||
| NCT04574284 | A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer | ||
| NCT03754244 | A Phase I Study of TQ-B3456 on Tolerance and Pharmacokinetics | ||
| NCT05046847 | A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3811 Tablets in Patients With Advanced Malignant Tumors | ||
| NCT06644417 | Clinical Study of TQA3605 Tablets Combined With Nucleoside (Acid) Analogs (NAs) Drugs Compared With NAs Drugs in the Treatment of Chronic Hepatitis B Virus (HBV) Infection | ||
| NCT04344158 | A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC) | ||
| NCT07569757 | Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma | ||
| NCT04002622 | Study of TQB2450 Injection in Subjects With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma | ||
| NCT04846634 | Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043) | ||
| NCT05426798 | Clinical Study of TQB2618 Injection in Combination With Demethylation Drugs in Patients With Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes | ||
| NCT05340530 | To Evaluate the Pharmacokinetic Effects of TQD3606 for Injection in Healthy Adult Subjects | ||
| NCT05028218 | A Clinical Study of TQB3824 in Subjects With Advanced Cancer | ||
| NCT07635290 | Anlotinib+Cadonilimab+PULSAR in Advanced Biliary Tract Cancer | ||
| NCT05735496 | Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers | ||
| NCT06031480 | Anlotinib and TQB2450 in Advanced Hepatocellular Carcinoma After Failure of Prior Immune Checkpoint Inhibitors | ||
| NCT03703596 | Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLC | ||
| NCT04964479 | A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC) | ||
| NCT06962267 | A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type) | ||
| NCT05830500 | Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma | ||
| NCT05380934 | A Clinical Trial of Safety and Tolerance of TQH3821 Tablets in Adult Healthy Subjects | ||
| NCT05970432 | A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis | ||
| NCT04325763 | A Study of TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC) | ||
| NCT05783921 | A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab Injection Combined With Chemotherapy in First-line Treatment of Relapsed/Metastatic Head and Neck Squamous Cell Carcinoma | ||
| NCT03456466 | Study of TQB2303 in Patients With Aggressive CD20 Positive Non-Hodgkin's Lymphoma | ||
| NCT02469883 | A Study of Sinotecean on Tolerance and Pharmacokinetics | ||
| NCT07327281 | A Clinical Trial Evaluating TQF3250 Capsules in Healthy Adult Subjects | ||
| NCT05913089 | A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer | ||
| NCT05922345 | Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy. | ||
| NCT06621095 | Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001) | ||
| NCT06929195 | Clinical Trial to Evaluate the Tolerance of TQB2210 Injection | ||
| NCT06433531 | A Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP) | ||
| NCT06408285 | A Study of TQC3927 Powder for Inhalation in Healthy Adult Subjects | ||
| NCT04952493 | Anlotinib or Penpulimab in Combination With RAI for DTC |
